Radiation Therapy

Eckert & Ziegler’s Radiation Therapy Segment is operated by Eckert & Ziegler BEBIG
 
Eckert & Ziegler BEBIG´s core business is the treatment of cancer by using brachytherapy, a special form of radiotherapy. Eckert & Ziegler BEBIG is a leader in brachytherapy in Europe. The company headquarters are in Belgium, with a production facility in Germany and subsidiaries throughout Europe and in India. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents, to support the international marketing of its product line.
The products and equipment provided by the company are intended for use by oncologists, radiologists, urologists and medical physicists.

Brachytherapy is a form of radiotherapy that treats cancer by irradiation from a short distance. Two different forms of brachytherapy are used today: permanent and temporary brachytherapy. In permanent brachytherapy, a small radioactive source is implanted in the body, while in temporary brachytherapy, the radioactive source is placed directly inside or close to the site of the tumor for a limited and defined period.

Brachytherapy is commonly used to treat tumours in numerous body sites, such as the cervix, endometrium, prostate, breast, oesophagus, lung & bronchus, lip & oral cavity, as well as the eyes.
  
Eckert & Ziegler BEBIG is listed on the Euronext stock exchange in Brussels and for more information you can also visit the website:
www.bebig.eu